Cetuximab in Refractory Squamous Cell Carcinoma of the Anal Canal

被引:5
|
作者
Rogers J.E. [1 ]
Eng C. [2 ]
机构
[1] Pharmacy Clinical Programs, U.T.M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston
[2] Department of Gastrointestinal Medical Oncology, U.T.M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston
关键词
Epidermal Growth Factor Receptor; Irinotecan; Cetuximab; Anal Canal; Vinorelbine;
D O I
10.1007/s12029-014-9626-7
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:198 / 200
页数:2
相关论文
共 50 条
  • [1] Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinoma
    De Dosso, Sara
    Martin, Vittoria
    Zanellato, Elena
    Frattini, Milo
    Saletti, Piercarlo
    TUMORI, 2010, 96 (04) : 627 - 628
  • [2] SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL
    Martin, F. T.
    Kavanagh, D.
    Waldron, R.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2009, 7 (04): : 232 - 237
  • [3] Squamous cell carcinoma of the anal canal
    Morton, Michael
    Melnitchouk, Nelya
    Bleday, Ronald
    CURRENT PROBLEMS IN CANCER, 2018, 42 (05) : 486 - 492
  • [4] Squamous cell carcinoma of the anal canal
    Rousseau, DL
    Thomas, CR
    Petrelli, NJ
    Kahlenberg, MS
    SURGICAL ONCOLOGY-OXFORD, 2005, 14 (03): : 121 - 132
  • [5] Squamous Cell Carcinoma of the Anal Canal
    Zaleski, Lisa
    Turiansky, George W.
    CUTIS, 2010, 85 (03): : 143 - 145
  • [6] Squamous cell carcinoma of the anal canal
    Mitchell, SE
    Mendenhall, WM
    Zlotecki, RA
    Carroll, RR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04): : 1007 - 1013
  • [7] Squamous cell carcinoma of the anal canal and anal margin
    Chawla, AK
    Willett, CG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (02) : 321 - +
  • [8] Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: Report of a case
    Phan, Lan K.
    Hoff, Paulo M.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (03) : 395 - 398
  • [9] Cetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canal
    Rogers, Jane E.
    Silva, Ninoska N.
    Eng, Cathy
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (05) : E82 - E85
  • [10] Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab
    Lerner, Jaren
    Michel, Miguel
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (04) : 1025 - 1028